INTRON A Redipen Interferon alfa-2b (rbe) 18 million IU/1.2mL injection cartridge Austrália - inglês - Department of Health (Therapeutic Goods Administration)

intron a redipen interferon alfa-2b (rbe) 18 million iu/1.2ml injection cartridge

merck sharp & dohme (australia) pty ltd - interferon alfa-2b -

INTRON A Interferon alfa-2b ( HSA-free ) 10 million IU/1mL injection vial Austrália - inglês - Department of Health (Therapeutic Goods Administration)

intron a interferon alfa-2b ( hsa-free ) 10 million iu/1ml injection vial

merck sharp & dohme (australia) pty ltd - interferon alfa-2b -

INTRON A Interferon alfa-2b (HSA-free) 25 million IU/2.5mL injection Austrália - inglês - Department of Health (Therapeutic Goods Administration)

intron a interferon alfa-2b (hsa-free) 25 million iu/2.5ml injection

merck sharp & dohme (australia) pty ltd - interferon alfa-2b -

INTRON A Interferon alfa-2b (HSA-free) 18 million IU/3mL injection Austrália - inglês - Department of Health (Therapeutic Goods Administration)

intron a interferon alfa-2b (hsa-free) 18 million iu/3ml injection

merck sharp & dohme (australia) pty ltd - interferon alfa-2b -

ROFERON-A interferon alfa-2a 9 million IU/0.5mL injection pre-filled syringe Austrália - inglês - Department of Health (Therapeutic Goods Administration)

roferon-a interferon alfa-2a 9 million iu/0.5ml injection pre-filled syringe

roche products pty ltd - interferon alfa-2a -

PLEGRIDY peginterferon beta-1a (rch) 63 microgram/0.5 mL and 94 microgram/0.5 mL solution for injection pre-filled pen TITRATION PACK Austrália - inglês - Department of Health (Therapeutic Goods Administration)

plegridy peginterferon beta-1a (rch) 63 microgram/0.5 ml and 94 microgram/0.5 ml solution for injection pre-filled pen titration pack

biogen australia pty ltd - peginterferon beta-1a, quantity: 94 microgram - injection, solution - excipient ingredients: arginine hydrochloride; water for injections; sodium acetate trihydrate; polysorbate 20; glacial acetic acid - plegridy is indicated for the treatment of relapsing forms of multiple sclerosis (ms) (see clinical trials).

PLEGRIDY peginterferon beta-1a (rch) 125 microgram/0.5 mL solution for injection pre-filled syringe Austrália - inglês - Department of Health (Therapeutic Goods Administration)

plegridy peginterferon beta-1a (rch) 125 microgram/0.5 ml solution for injection pre-filled syringe

biogen australia pty ltd - peginterferon beta-1a, quantity: 125 microgram - injection, solution - excipient ingredients: sodium acetate trihydrate; water for injections; glacial acetic acid; arginine hydrochloride; polysorbate 20 - plegridy is indicated for the treatment of relapsing forms of multiple sclerosis (ms) (see clinical trials).

PLEGRIDY peginterferon beta-1a (rch) 63 microgram/0.5 mL and 94 microgram/0.5 mL solution for injection pre-filled syringe TITRATION PACK Austrália - inglês - Department of Health (Therapeutic Goods Administration)

plegridy peginterferon beta-1a (rch) 63 microgram/0.5 ml and 94 microgram/0.5 ml solution for injection pre-filled syringe titration pack

biogen australia pty ltd - peginterferon beta-1a, quantity: 94 microgram - injection, solution - excipient ingredients: glacial acetic acid; polysorbate 20; arginine hydrochloride; sodium acetate trihydrate; water for injections - plegridy is indicated for the treatment of relapsing forms of multiple sclerosis (ms) (see clinical trials).

PLEGRIDY peginterferon beta-1a (rch) 125 microgram/0.5 mL solution for injection pre-filled pen Austrália - inglês - Department of Health (Therapeutic Goods Administration)

plegridy peginterferon beta-1a (rch) 125 microgram/0.5 ml solution for injection pre-filled pen

biogen australia pty ltd - peginterferon beta-1a, quantity: 125 microgram - injection, solution - excipient ingredients: sodium acetate trihydrate; glacial acetic acid; water for injections; polysorbate 20; arginine hydrochloride - plegridy is indicated for the treatment of relapsing forms of multiple sclerosis (ms) (see clinical trials).

REBIF 44 interferon beta-1a (rch) 132 microgram/1.5mL solution for injection multidose cartridge Austrália - inglês - Department of Health (Therapeutic Goods Administration)

rebif 44 interferon beta-1a (rch) 132 microgram/1.5ml solution for injection multidose cartridge

merck healthcare pty ltd - interferon beta-1a, quantity: 88 microgram/ml - injection, solution - excipient ingredients: methionine; acetic acid; mannitol; poloxamer; water for injections; benzyl alcohol; sodium hydroxide - rebif is indicated for the treatment of: ? patients with a single demyelinating event in the central nervous system with an active inflammatory process, if alternative diagnoses have been excluded, and if they are determined to be at high risk of developing clinically definite multiple sclerosis. high risk can be inferred from cerebral mri with 2 or more lesions suggestive of demyelination.,? ambulatory patients with multiple sclerosis who have experienced two or more relapses within the last 2 years. rebif therapy should not be initiated in secondary progressive ms patients who no longer experience relapses.?